ASX lithium shares have been in the spotlight extensively over September, but which shares performed the best?

In this post, we’ve rounded up the three best performers for the month of September, with the prerequisite that they are traded on the ASX and have a market capitalisation of at least $100 million.

Let’s cover which ASX lithium shares beat their peers over the last month.

Global Lithium Resources Ltd (ASX: GL1)

Global Lithium was the biggest winner in September, gaining 26.31%. Shares opened for $1.71 on 1 September and closed for $2.16 at the end of the month.

Several developments helped keep Global Lithium’s share price buoyant, including signing a memorandum of understanding with battery manufacturer SK On Co on 29 September. My Fool colleague James notes that the memorandum will see the companies cooperate on developing downstream integrated battery-grade lithium assets, among other ventures.

Earlier in the month, the company gave a project update for its Marble Bar Lithium Project in Western Australia. High yields of lithium spodumene concentrate were announced at the site with high lithium recoveries.

Pilbara Minerals Ltd (ASX: PLS)

Pilbara takes the silver medal for September, with its shares increasing 25.27% for the month. Shares opened for $3.64 on 1 September and ended at $4.56 when the month finished.

One standout development for Pilbara was the result of its lithium auction posted on 21 September. When the Fool reported the news, the company’s shares made a new all-time high of $5.03.

The company also received a record bid from the auction of US$6,988 per dmt. That’s up from the previous bids of US$6,188 per dmt in July and US$6,350 per dmt in August of this year.

Pilbara also received some positive coverage from brokers throughout the month. This included Wilsons making positive statements about the company on 26 September.

Wilsons is bullish on the expectations of Pilbara’s production increasing in the future, stating:

Spodumene production is expected to increase to ~1 million tonnes by FY28, up from 360 kilo tonnes in FY22.

Argosy Minerals Limited (ASX: AGY)

And finally, there’s Argosy Minerals, whose shares increased 24.69% in September. Shares opened for $0.405 on 1 September and closed for $0.505 at the end of the month.

Like other ASX lithium shares on this list, Argosy also had some positive developments to help end September with a substantial share price gain. This included an update for its Rincon Lithium Project in Argentina on 23 September. One highlight is that its rotary drilling program progressed better than expected, drilling to 350 metres at its PRP-03 production well and 253 metres at its PRP-04 well.

And on 13 September, the company was included in a roundup post of companies that engage in the production of graphite, which goes hand in hand with the demand for lithium as a critical element in the creation of batteries for electric vehicles, among other uses.

Argosy has a graphite project in Namibia, and production of the material is currently pending further review from the company while it considers funding opportunities.

How did other ASX lithium shares perform?

Below is a table of ASX lithium shares with a market cap of at least $100 million and their share price performance in September.

Ticker	September % change
RIO	-0.27
PLS	25.27
MIN	4.64
AKE	0.00
LTR	-12.35
SYA	-18.96
CXO	-20.21
DEG	9.47
INR	-1.55
LKE	-21.49
VUL	-9.31
AGY	24.69
NMT	-18.47
PLL	-5.61
GLN	-7.36
GL1	28.65
ASN	-18.05
LPI	-14.28
LRS	-19.99
LPD	-23.33
POS	-11.76
AVL	-26.08
JRL	-8.98
1MC	-16.00
NVA	-31.38
ESS	2.22
DEV	-26.19
EUR	-9.41

Below is a chart of this data in the table above.

The post These were the 3 best performing ASX lithium shares in September appeared first on The Motley Fool Australia.

.

More reading

• These were the 5 best-performing ASX All Ords shares in September
• These were the best performers on the ASX 200 in September
• Here are the big ASX lithium share winners and losers on Friday
• If I’d invested $1,000 in Pilbara Minerals shares at the start of 2022, here’s what I’d have now
• Why Cogstate, Global Lithium, Premier, and Woodside shares are charging higher

Motley Fool contributor Matthew Farley has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/aMlvFk8

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

As her firm’s flagship fund, the ARK Innovation ETF, surged 148.7% during 2020, Cathie Wood rose to prominence as a widely followed voice in the investment community. Bets on major pandemic winners like Block, Teladoc, and Zoom paid off well but have since cooled off as a result of the current uncertain macroeconomic situation. Nonetheless, people pay a great deal of attention to what Wood says about stocks and investments. 

The renowned investor, whose firm focuses on disruptive and innovative companies, recently reiterated her bullishness on Bitcoin (CRYPTO: BTC) in particular. And investors should take notice. 

As bullish as ever 

At the recent SALT Conference in New York, where investment professionals and policy makers get together to discuss a host of topics like alternative investments, healthcare, and sustainability, Cathie Wood spoke on stage about her belief in the promise of cryptocurrencies and blockchain technology. And to be specific, she cited Bitcoin as a huge winner over the rest of the decade, once again expressing more confidence in her belief in the world’s most valuable cryptocurrency.   

Wood also talked about how Bitcoin and cryptocurrencies have started to behave more like growth tech stocks as a result of investors putting them all in the same bucket of risky assets. And the aggressive interest rate hikes by the Federal Reserve, to curb soaring inflation, has put downward pressure on their valuations. 

Bitcoin’s price drop of 59% in 2022 (as of this writing) might one day prove to be an extremely favorable buying opportunity for long-term investors, Wood believes. 

Bitcoin has massive upside 

Earlier this year, Ark Invest laid out the bullish case for Bitcoin in its Big Ideas 2022 report, which Wood spoke about at the SALT conference. The firm believes, according to its analysis, that Bitcoin’s price could exceed $1 million per coin by 2030. That’s quite a lofty target, but it hinges on Bitcoin achieving a certain level of penetration in eight different use-cases.  

If Bitcoin’s network captures half of the global remittance market, that’s $300 billion in value. If Bitcoin commands 10% of the money supply in emerging economies (excluding the four biggest countries) by 2030, that’s $2.8 trillion. And if 25% of settlement volume between U.S. banks shifts to Bitcoin, that would create another $3.8 trillion in value. 

Besides these three instances of actual utility, Ark sees Bitcoin becoming a mainstream asset for government treasury reserves, high-net-worth individuals, institutional investors, and corporate balance sheets at minor allocations. What’s more, Wood’s firm sees Bitcoin taking 50% of gold’s market cap by 2030. Add these scenarios up, and that’s another $21.6 trillion in value accruing to the Bitcoin network. 

Based on the crypto’s market cap of $375 billion as of this writing, Ark’s target valuation of $28.5 trillion would equal a more than 70-fold gain between now and the end of the decade. This incredible hypothetical performance would without a doubt beat the S&P 500‘s total return during the same time, and it would make those investors who closely follow Cathie Wood’s words rich.   

But putting your entire portfolio into Bitcoin would be a risky move, because the technology is still early in its adoption and development. Plus, it’s incredibly volatile. Therefore, it’s best to allocate to Bitcoin what you can afford to lose, say no more than 3% of your portfolio. By keeping the allocation that low, it will help investors sleep better at night. And if Bitcoin skyrockets, it will certainly have a major positive impact on the financial well-being of those who were bold enough to buy and hold over the years.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post One of the smartest investors says buy the dip on Bitcoin appeared first on The Motley Fool Australia.

.

More reading

• Why buying Bitcoin might be the best investment right now: broker
• Here’s what one billionaire thinks about crypto right now
• Has the Bitcoin price found a floor?
• Why Bitcoin, Ethereum, and Solana moved higher on Tuesday
• Bitcoin price rallies 6% to leap back over US$20,000

Neil Patel has positions in Bitcoin, Block, Inc., and Teladoc Health. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Bitcoin, Block, Inc., Teladoc Health, and Zoom Video Communications. The Motley Fool Australia has positions in and has recommended Block, Inc. The Motley Fool Australia has recommended Zoom Video Communications. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/6v9zAkD

It’s a public holiday in many Australian states today, but that hasn’t stopped the ASX share market from opening.

Typically, the ASX only closes on national public holidays, such as Good Friday, ANZAC Day, and Christmas. 

So, you’re still able to buy and sell shares in your favourite ASX companies today.

But given it’s a public holiday in Queensland, New South Wales, ACT, and South Australia, we’re seeing reduced volume and trading activity as people make the most of their long weekend.

How are ASX shares performing today?

All three US benchmarks fell by around 1.5% on Friday, providing a negative lead for the ASX today.

But the S&P/ASX 200 Index (ASX: XJO) shrugged off this gloomy sentiment to rise by as much as 0.5% this morning.

These gains have since reversed, with the ASX 200 down 0.9% at the time of writing to sit at 6,418 points.

As has often been the case in recent months, the ASX tech sector is bearing the brunt of the fall. The S&P/ASX All Technology Index (ASX: XTX) has shed 2.5%.

Meanwhile, the communication services, consumer discretionary, and financials sectors have all dropped by around 1%.

Top ASX 200 risers and fallers

In early afternoon trade, the Iluka Resources Limited (ASX: ILU) share price is leading the way. It’s lit up by 2.1% despite there being no news from the mineral sands company.

BlueScope Steel Limited (ASX: BSL) is the next best ASX 200 performer, rising 1.4% against a backdrop of red-hot steel prices.

Rounding out the top three is Santos Ltd (ASX: STO), which has climbed 1.3% at the time of writing on the back of up swinging oil prices.

But while some ASX 200 shares buck the broader market weakness, there are many more in the red today.

The West African Resources Ltd (ASX: WAF) is currently at the back of the pack, tumbling 8.6% to 96 cents. The company released an operations update today in response to a change in the military leadership in Burkina Faso on the weekend.

The Core Lithium Ltd (ASX: CXO) share price is also feeling worse for wear, slumping 7.2% to $1.025. Core Lithium shares emerged from a trading halt today after the company completed a $100 million institutional placement at an offer price of $1.03.

The Chalice Mining Ltd (ASX: CHN) share price is also coming under pressure. It’s dropped 7.1% to currently sit at $3.65 despite there being no news out of Chalice today.

The post Yes, the ASX is open today, and here’s what’s happening appeared first on The Motley Fool Australia.

.

More reading

• Why 5E Advanced Materials, Appen, Core Lithium, and Infomedia shares are dropping
• Why is the Core Lithium share price sinking 8% today?
• 5 things to watch on the ASX 200 on Monday
• Here are the top 10 ASX 200 shares today
• Here are the big ASX lithium share winners and losers on Friday

Motley Fool contributor Cathryn Goh has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Fl16MuW

The S&P/ASX 200 Index (ASX: XJO) has started the week in a subdued fashion. In afternoon trade, the benchmark index is down 0.1% to 6,472 points.

Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping:

5E Advanced Materials Inc (ASX: 5EA)

The 5E Advanced Materials share price has continued its slide and is down a further 18% to $1.67. Investors have been selling this minerals exploration and production company’s shares since the release of its results and the announcement of the surprise exit of its CEO last week.

Appen Ltd (ASX: APX)

The Appen share price is down 2% to $3.06. Appen’s shares have come under pressure over the last couple of trading sessions due to concerns over demand for its services. This follows a disappointing update out of one of its biggest customers, Meta.

Core Lithium Ltd (ASX: CXO)

The Core Lithium share price is down 6% to $1.04. Investors have been selling this lithium miner’s shares after it completed its institutional placement. Core Lithium has raised $100 million before costs at a discount of $1.03 per new share. In other news, the company revealed that it has sold 15,000 dry metric tonnes (dmt) of spodumene via a digital auction. Demand for the spodumene DSO material was strong, which led to Core Lithium commanding a sale price of US$951/dmt.

Infomedia Limited (ASX: IFM)

The Infomedia share price is down 6% to $1.10. This morning the auto industry software provider revealed that it has not received binding takeover offers from Solera Holdings or a consortium comprising TA Associates and Viburnum Funds by its deadline. As a result, it has closed the virtual data room to Solera and the consortium and requested that they destroy or return all confidential information.

The post Why 5E Advanced Materials, Appen, Core Lithium, and Infomedia shares are dropping appeared first on The Motley Fool Australia.

.

More reading

• Yes, the ASX is open today, and here’s what’s happening
• Why is the Core Lithium share price sinking 8% today?
• Here are the big ASX lithium share winners and losers on Friday
• Why has the Core Lithium share price just been halted?
• Why has the Appen share price just dropped to a new 5-year low?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Appen Ltd and Infomedia. The Motley Fool Australia has recommended Infomedia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/DPmv0Jk

The Mesoblast Limited (ASX: MSB) share price is surging today on the back of a product update.

Mesoblast shares are lifting 7.69% today and are currently trading at 84 cents. For perspective, the S&P/ASX 200 Index (ASX: XJO) is down 0.33% today.

Let’s take a look at what’s impacting the Mesoblast share price today.

Mesoblast share price rises on “major milestone”

Mesoblast is working on allogeneic cellular medicines for inflammatory diseases.

Investors appear to be buying up Mesoblast shares after the company provided an update on a US Food and Drug Administration (FDA) application.

Mesoblast supplied the FDA with “substantial new information” on the use of remestemcel-L to treat children with steroid-refractory acute graft versus host disease (SR-aGVHD).

This new information is in response to a Complete Response Letter (CRL) from the FDA received in September 2020.

Mesoblast said this is a “major milestone” in the company’s response to the FDA.

Commenting on the news, chief executive Dr Silviu Itescu said:

The submission summarizes controlled data providing further evidence of remestemcel-L’s ability to save lives.

Additionally, the improved process controls we have put in place to assure robust and consistent commercial product, together with a potency assay that predicts consistent survival outcomes, makes remestemcel-L a compelling treatment for these children.

Mesoblast share price snapshot

The Mesoblast share price has fallen 49% in the past year, while it has lost 40% in the year to date. In the last month, Mesoblast shares have shed more than 1%.

In comparison, the ASX 200 has shed 10% in the past year.

Mesoblast has a market capitalisation of more than $619 based on the current share price.

The post Why is the Mesoblast share price surging 8% on Monday? appeared first on The Motley Fool Australia.

.

More reading

• Why Mesoblast, Unibail-Rodamco-Westfield, Widgie Nickel, and Yancoal are rising
• This board member pulled the trigger on more Mesoblast shares
• Why has the Mesoblast share price marched 14% higher in 6 days?
• Looking to buy Mesoblast shares? Here’s the latest on where the ASX biotech is at with the FDA

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/pd4R1QO

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decline. At the time of writing, the benchmark index is down 0.3% to 6,454.5 points.

Four ASX shares that are not letting that hold them back are listed below. Here’s why they are pushing higher:

Mesoblast limited (ASX: MSB)

The Mesoblast share price is up almost 8% to 84 cents. Investors have been buying this biotech company’s shares after it confirmed the submission of substantial new information on clinical and potency assay items to the FDA. This is for items identified by the regulator for its remestemcel-L product in the treatment of children with steroid-refractory acute graft versus host disease.

Unibail-Rodamco-Westfield (ASX: URW)

The Unibail-Rodamco-Westfield share price is up over 4% to $3.20. This has been driven by news that the shopping centre operator has completed the sale of the Villeneuve 2 centre in the Lille region of France to Ceetrus. This means that the company has now completed 3.2 billion euros of disposals, representing 80% of its 4 billion euros European disposal programme.

Widgie Nickel Ltd (ASX: WIN)

The Widgie Nickel share price is up 28% to 30 cents. This follows the announcement of a major lithium discovery from the company’s Mt Edwards project. Management commented: “This initial reconnaissance work identifying high grade spodumene over a significant strike length couldn’t be a better outcome for Widgie.”

Yancoal Australia Ltd (ASX: YAL)

The Yancoal share price is up 2% to $5.78. This morning this coal miner announced that it will make a major debt repayment. Yancoal advised that it intends to prepay US$1.0 billion of debt from available cash on 4 October. This consists of payment toward Yancoal’s Syndicated Facility and its unsecured related-party loans. This is expected to deliver an approximate US$207 million reduction in total finance cost over the loan periods.

The post Why Mesoblast, Unibail-Rodamco-Westfield, Widgie Nickel, and Yancoal are rising appeared first on The Motley Fool Australia.

.

More reading

• Why is the Mesoblast share price surging 8% on Monday?
• Guess which ASX mining share is rocketing 50% on a ‘high-grade’ lithium find
• ‘Willingness to pay a premium’: ASX coal shares boom again on Wednesday
• September living up to its ‘worst month of the year’ reputation as ASX 200 finally cracks
• Why are ASX 200 coal shares smashing it out of the park on Tuesday?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/3r0eYAI

The CSL Limited (ASX: CSL) share price has gone through plenty of volatility in 2022, just like the S&P/ASX 200 Index (ASX: XJO). But what happened in September?

Shares in the biotech giant started the year at around $291 and are now sitting at just over $283. So, there has been a bit of a decline this year.

But market declines have gone further recently as investors get used to the higher interest rates as central banks try to tackle strong inflation.

How did the CSL share price perform in September?

Last month, CSL shares dropped by around 3%. Zoom in further and we see that between 8 September 2022 and the end of the month, they fell by approximately 5%.

How does this compare to the ASX 200? Let’s have a look.

In September, the ASX 200 declined by 7.3%. From 8 September 2022 to the end of the month, it dropped by 5.5%.

So that means that CSL outperformed the ASX 200 by 4% over the month of September.

For one of the ASX’s biggest companies (as measured by market capitalisation), that much outperformance in a short amount of time is useful for shareholders.

Why did it outperform?

Ultimately, it’s up to the buyers and sellers to decide what prices to transact at.

ASX healthcare shares can have a reputation for being defensive and having resilient earnings. It’s possible that CSL’s profit could stay robust, even during economic difficulties.

Another factor to consider is that CSL reports its financials in US dollars. The Australian dollar started September worth US 68 cents but by the end of the month, it had fallen to US 64 cents. Assuming it generates the same profit in US dollar terms, a lower Aussie dollar gives support to the CSL share price, which is valued in Australian dollars.

Investors may also be taking into account the guidance that the company gave when it released its FY22 result. The guidance can influence investor thoughts about the CSL share price.

CSL said that it had a “strong mid-term outlook” as COVID receded, and a “promising cluster” of research and development programs that were nearing completion.

The company said that it was expecting “strong” plasma collections, though the higher cost of plasma was continuing. It’s rebuilding inventory to strengthen resilience.

In its vaccine business, CSL said that there was ongoing northern hemisphere demand for flu vaccines and it expected continued growth from product differentiation.

But, CSL did acknowledge it was continuing to navigate a “challenging external cost environment”.

Excluding the impact of the Vifor acquisition, the company expected to generate net profit after tax (NPAT) of between US$2.4 billion to US$2.5 billion in FY23. That compares to FY22 net profit of US$2.25 billion. Profit, and expectations of profit, can have a big impact on the CSL share price.

The post Did CSL shares manage to generate healthy returns in September? appeared first on The Motley Fool Australia.

.

More reading

• CSL share price jumps despite JP Morgan’s latest caution
• When might the CSL share price top $300 again?
• Move over gold: Could ASX 200 healthcare shares be the new ‘safe-haven’ investments?
• Experts name 2 star blue chip ASX 200 shares to buy now
• ‘Long term view’: Expert names 2 punished ASX shares with ‘bright outlook’

from The Motley Fool Australia https://ift.tt/M3TyO7h

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Investors have had a rough go of it in 2022. All three major indices are in a bear market, which is a drawdown of at least 20% from the high. However, many well-known individual stocks are down far more.

Out of the 10 largest stocks by market cap in the Nasdaq Composite (NASDAQ: .IXIC), seven are down over 30% from their all-time high, and two are down over 60%. Many growth stocks are down over 80% from their highs.

Investing is easy when most stocks seem only to go up. But when an investment portfolio is down big, it can be challenging to stay even-keeled and focus on the long term. You can’t wave a magic wand and wish a stock to go up. But you can take actionable steps to position your portfolio to outlast a prolonged bear market. Here are three steps worth considering now.

1. Give your portfolio a checkup

Revisiting your holdings is a good practice, no matter the market cycle. But the exercise can be taken a step further in a bear market. Outlasting volatility becomes a little easier if you remember why you bought a company in the first place.

For most quality businesses, the investment thesis probably hasn’t changed between a year ago and today. Granted, margins may be under pressure, earnings may be declining, and growth rates may be slowing. But businesses don’t experience linear growth. Rather, ebbs and flows are simply par for the course.

A good example of a company whose business remains largely the same is Google’s parent company Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL). Due to its dependence on advertising revenue and a strong economy, Alphabet’s business is facing short-term headwinds. However, the investment thesis for Alphabet hasn’t changed at all. Alphabet stock may be down 35% from its all-time high — around the same as the Nasdaq Composite. But that doesn’t mean that Alphabet, as a company, is in trouble.

The same can’t be said for companies that aren’t free-cash-flow positive, are unprofitable, are losing their competitive advantages to larger companies, or depend on debt or equity financing to stay afloat. Rising interest rates and a challenging business climate are headwinds for most companies. But for some, they could lead to unsustainable cash burn and a reason to reconsider owning the company.

2. Update your savings plan

Over time, dollar-cost averaging into your favourite companies has been a tried-and-true method for compounding wealth. Saving more can be a great way to accumulate additional shares of your favourite companies, especially when they are on sale.

Saving more money isn’t easy. But purposeful saving can be achieved by making a list of companies to buy every two weeks, month, or whatever increment of time is best for you.

Bear markets have historically been excellent times to add shares. The problem for most investors is that they don’t have cash on the sidelines to buy stocks on the cheap. However, investors who are still in the asset accumulation stage of their lives — as in they make more money than they spend — are at an advantage because they can put more money to work and likely have that capital go even further.

3. Zoom out and focus on your financial goals

No one likes losing money. But an even worse feeling is losing money in an unexpected way by owning companies that don’t fit your personal risk tolerance or investment time horizon.

Investors that are in the asset accumulation stage of their lives can afford to take more risks by letting an investment thesis play out and outlast the volatility. However, investors in the asset distribution stage of their life are spending more than they are making and therefore tend to be more risk averse.

If you are a retiree with high-risk, high-reward stocks that could lead to missing your financial goals, it may be time to rethink some positions. The same disconnect between financial goals and investment holdings can occur if an investor winds up owning too many stodgy companies when they don’t mind taking on more risk when asset values are lower.

In a bear market, it’s important to remember that investing isn’t about beating the market. It’s about reaching your financial goals in a way that is comfortable, lets you sleep at night, and is aligned with your risk tolerance. In a bull market, it’s easy to be complacent. But bear markets have a habit of catching investors off-guard. For investors whose portfolios are already mostly in line with what they want to own, the best course of action may be to simply do nothing at all.

Resisting fight or flight

It’s human nature to want to do something, anything, to rectify steep losses. But often, heavily trading through a bear market can do more harm than good. By taking action through a portfolio checkup, updating your savings plan, and bridging the gap between your holdings and your financial goals, an investor can feel a sense of empowerment even if their screen continues to be painted red with falling stock prices.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Do these 3 things now if your portfolio is down big appeared first on The Motley Fool Australia.

.

More reading

• Did CSL shares manage to generate healthy returns in September?
• Here’s what happened to the BHP share price in September
• Guess which ASX mining share is rocketing 50% on a ‘high-grade’ lithium find
• Bubs share price higher on US FDA news
• 3 high-growth US stocks that could be worth $1 trillion in 10 years – or sooner

Daniel Foelber has positions in Alphabet (A shares). Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet (A shares) and Alphabet (C shares). The Motley Fool Australia has recommended Alphabet (A shares) and Alphabet (C shares). The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/nQaFKMm

The BHP Group Ltd (ASX: BHP) share price was out of form in September.

During the month, the mining giant’s shares lost 5.1% of their value to end the period at $38.52.

Why did the BHP share price tumble in September?

The BHP share price came under pressure in September amid broad market weakness after rising rates sparked fears of a global recession.

A global recession could be bad news for BHP and other mining shares. That’s because it has the potential to lead to softening demand for commodities, which could in turn put pressure on prices and ultimately mining profits and dividends.

It is worth noting, though, that the BHP share price actually outperformed the ASX 200 index last month, which lost a very disappointing 7.3% of its value.

This relative outperformance is likely to have been driven by BHP’s exposure to one booming commodity – coal.

With coal prices rising to sky high levels and tipped to remain that way for some time to come, some investors are betting on BHP’s earnings holding up despite the current uncertain economic environment.

Are BHP’s shares a buy?

One leading broker that sees a lot of value in the BHP share price is Macquarie.

Late last month, the broker retained its outperform rating and lifted its price target on the miner’s shares to $44.00. This implies potential upside of 14% for investors over the next 12 months.

Macquarie made the move after upgrading its earnings estimates for BHP by approximately 5% through to FY 2026 to reflect higher coal prices.

Another positive is that Macquarie is expecting the Big Australian to pay a fully franked dividend of ~$2.60 per share in FY 2023. This equates to a 6.75% dividend yield, which stretches the total potential return to almost 21%.

The post Here’s what happened to the BHP share price in September appeared first on The Motley Fool Australia.

.

More reading

• Top brokers name 3 ASX shares to buy next week
• Experts name 2 ASX 200 dividend shares to buy next week
• Why is the BHP share price having such a stellar end to the week?
• ASX 200 dividend shares suffer September sell-off
• Guess which ASX 200 mining shares are outpacing BHP today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/CR0ljoZ

The Widgie Nickel Ltd (ASX: WIN) share price is having an incredible start of the week.

In early trade, the mineral exploration company’s shares were up as much as 51% to 35.5 cents.

The Widgie Nickel share price has since pulled back a touch but remains up 34% to 31.5 cents at the time of writing.

Why is the Widgie Nickel share price rocketing higher?

Investors have been scrambling to buy the mineral exploration company’s shares today following the announcement of a major discovery.

However, unlike what you might expect from the company’s name, Widgie Nickel has not found nickel. Rather, it has found high-grade lithium bearing pegmatites at the newly named “Faraday prospect” of its Mt Edwards project.

According to the release, lithium bearing pegmatites outcropping over a 600-metre strike with surface expressions of up to 25 meters wide have been identified at the prospect.

Management believes these early stage exploration results are extremely encouraging and provide the company with the opportunity to significantly increase its lithium exploration activity within the highly prospective tenement package.

Field work is expected to commence immediately to drill test high-priority targets at the Faraday prospect as well as detailed mapping, soil and rock chip sampling across the Widgie tenure.

‘Couldn’t be a better outcome’

Widgie Nickel’s managing director, Steve Norregaard, was very pleased with the news. He said:

This initial reconnaissance work identifying high grade spodumene over a significant strike length couldn’t be a better outcome for Widgie. To think we have 170,000t of contained nickel and we now can lay claim to hosting complementary and widespread lithium pegmatites in this world class lithium corridor.

Widgie looks forward with great anticipation to getting a drill rig on this highly prospective target which will only complement the existing drilling effort on our nickel resources.

The post Guess which ASX mining share is rocketing 50% on a ‘high-grade’ lithium find appeared first on The Motley Fool Australia.

.

More reading

• Bubs share price higher on US FDA news
• 3 high-growth US stocks that could be worth $1 trillion in 10 years – or sooner
• Here are 2 ASX 200 dividend shares that analysts have slapped buy ratings on
• Why has the Vanguard Index International Shares ETF been getting hammered lately?
• If I’d invested $1,000 in Woodside shares at the start of 2022, here’s what I’d have now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/tAd7WCc